Table I.
Clinical characteristics of the patients (n=83).
| Clinical characteristic | Patients, n (%) |
|---|---|
| Age (years) | |
| Mean | 69±13 |
| Range | 35–88 |
| Gender | |
| Male | 46 (55) |
| Female | 37 (45) |
| Performance statusa | |
| 0 | 46 (55.4) |
| 1 | 16 (19.3) |
| 2 | 4 (4.8) |
| 3 | 2 (2.4) |
| 4 | 5 (6.0) |
| Not available | 10 (12.0) |
| Mental disorders | |
| Anxiety disorder | 7 (8.4) |
| Depressive disorder | 8 (9.6) |
| Bipolar disorder | 1 (1.2) |
| Alzheimer's disease | 4 (4.8) |
| Total | 20 |
| Psychotropic medications | |
| Benzodiazepine | 13 (15.7) |
| Serotonin uptake inhibitor | 5 (6.0) |
| Anti-epileptic medication | 1 (1.2) |
| Acetylcholinestase inhibitor | 1 (1.2) |
| Anti-NMDA receptor | 1 (1.2) |
| Total | 21 |
a
According to the World Health Organization. NMDA, N-methyl-D-aspartate.